Showing results (191-200 of 347) with videos related to
Sort By:
Pageof 35
Kidney International|March 11, 2011
Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney diseaseStephen L Seliger, Amy D Zhang, Matthew R Weir, et al.Kidney International|June 29, 2016
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitorsMatthew R Weir, George L Bakris, Coleman Gross, et al.Lancet (London, England)|December 11, 2012
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trialMichael A Weber, Kenneth Jamerson, George L Bakris, et al.Transplantation|December 10, 2009
The independent association between serum uric acid and graft outcomes after kidney transplantationAbdolreza Haririan, Joseph M Nogueira, Joseph M Noguiera, et al.Journal of the American Heart Association|April 25, 2019
Magnitude of the Difference Between Clinic and Ambulatory Blood Pressures and Risk of Adverse Outcomes in Patients With Chronic Kidney DiseaseElaine Ku, Raymond K Hsu, Delphine S Tuot, et al.Hypertension (Dallas, Tex. : 1979)|November 9, 2020
Adverse Health Outcomes Associated With Refractory and Treatment-Resistant Hypertension in the Chronic Renal Insufficiency CohortMichael G Buhnerkempe, Vivek Prakash, Albert Botchway, et al.European Journal of Heart Failure|October 14, 2015
Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitorsBertram Pitt, George L Bakris, David A Bushinsky, et al.The American Journal of Medicine|November 29, 2017
Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS InhibitorsMatthew R Weir, David A Bushinsky, Wade W Benton, et al.Journal of Cardiovascular Pharmacology and Therapeutics|June 7, 2017
Evaluation of the Potential for Drug Interactions With Patiromer in Healthy VolunteersLawrence J Lesko, Elliot Offman, Christine Taylor Brew, et al.European Journal of Heart Failure|April 22, 2009
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL programHenry Krum, Sean P Curtis, Amarjot Kaur, et al.Pageof 35